Veloxis Pharmaceuticals A/S Announces Strategic Agreement for Chiesi Farmaceutici S.p.A. to Commercialize and Distribute Its Investigational Drug Candidate LCP-Tacroâ¢ in Europe, Turkey and CIS Countries and Revised Outlook